Expression of Bmi-1 in pediatric brain tumors as a new independent prognostic marker of patient survival

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Farivar, Shirin ^a   Zati Keikha, Reza ^a   Shiari, Reza ^b   Jadali, Farzaneh ^b  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; BMI1 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BRAIN TISSUE; BRAIN TUMOR; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHILD; EPENDYMOMA; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY; PROGNOSIS; SURVIVAL;

BRAIN NEOPLASMS; CHILD; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; POLYCOMB REPRESSIVE COMPLEX 1; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84883185666     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/192548     Document Type: Article

References (28)

1. Li J., Thompson T. D., Miller J. W., Pollack L. A., Stewart S. L., Cancer incidence among children and adolescents in the United States, 2001-2003. Pediatrics 2008 121 6 e1470 e1477 2-s2.0-48949101071 10.1542/peds.2007-2964
2. Faury D., Nantel A., Dunn S. E., Guiot M.-C., Haque T., Hauser P., Garami M., Bognár L., Hanzély Z., Liberski P. P., Lopez-Aguilar E., Valera E. T., Tone L. G., Carret A.-S., Del Maestro R. F., Gleave M., Montes J.-L., Pietsch T., Albrecht S., Jabado N., Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. Journal of Clinical Oncology 2007 25 10 1196 1208 2-s2.0-34247131323 10.1200/JCO.2006.07.8626
3. Sung T., Miller D. C., Hayes R. L., Alonso M., Yee H., Newcomb E. W., Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Brain Pathology 2000 10 2 249 259 2-s2.0-0034079777
4. Perilongo G., Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma. Journal of Neuro-Oncology 2005 75 3 301 307 2-s2.0-29644439334 10.1007/s11060-005-6754-8
5. Kaatsch P., Rickert C. H., Kühl J., Schüz J., Michaelis J., Populationbased epidemiologic data on brain tumors in German children. Cancer 2001 92 12 3155 3164
6. Simon J. A., Kingston R. E., Mechanisms of Polycomb gene silencing: knowns and unknowns. Nature Reviews Molecular Cell Biology 2009 10 10 697 708 2-s2.0-70349469565 10.1038/nrm2763
7. Sparmann A., Van Lohuizen M., Polycomb silencers control cell fate, development and cancer. Nature Reviews Cancer 2006 6 11 846 856 2-s2.0-33750379420 10.1038/nrc1991
8. Orlando V., Polycomb, epigenomes, and control of cell identity. Cell 2003 112 5 599 606 2-s2.0-0037423933 10.1016/S0092-8674(03)00157-0
9. Molofsky A. V., Pardal R., Iwashita T., Park I.-K., Clarke M. F., Morrison S. J., Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003 425 6961 962 967 2-s2.0-0242667922 10.1038/nature02060
10. Park I.-K., Qian D., Kiel M., Becker M. W., Pihalja M., Weissman I. L., Morrison S. J., Clarke M. F., Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003 423 6937 302 305 2-s2.0-0038349957 10.1038/nature01587
11. Vonlanthen S., Heighway J., Altermatt H. J., Gugger M., Kappeler A., Borner M. M., Lohuizen M. V., Betticher D. C., The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. British Journal of Cancer 2001 84 10 1372 1376 2-s2.0-0035906853 10.1054/bjoc.2001.1791
12. Van Kemenade F. J., Raaphorst F. M., Blokzijl T., Fieret E., Hamer K. M., Satijn D. P. E., Otte A. P., Meijer C. J. L. M., Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001 97 12 3896 3901 2-s2.0-0035877978 10.1182/blood.V97.12.3896
13. Kim J. H., Yoon S. Y., Kim C.-N., Joo J. H., Moon S. K., Choe I. S., Choe Y.-K., Kim J. W., The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Letters 2004 203 2 217 224 2-s2.0-0346094301 10.1016/j.canlet.2003.07.009
14. Honig A., Weidler C., Häusler S., Krockenberger M., Buchholz S., Köster F., Segerer S. E., Dietl J., Engel J. B., Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer. Anticancer Research 2010 30 5 1559 1564 2-s2.0-77954600171
15. Balasubramanian S., Lee K., Adhikary G., Gopalakrishnan R., Rorke E. A., Eckert R. L., The Bmi-1 polycomb group gene in skin cancer: regulation of function by (-)-epigallocatechin-3-gallate. Nutrition Reviews 2008 66 1 S65 S68 2-s2.0-48349123382 10.1111/j.1753-4887.2008.00071.x
16. Cui H., Hu B., Li T., Ma J., Alam G., Gunning W. T., Ding H.-F., Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. The American Journal of Pathology 2007 170 4 1370 1378 2-s2.0-34247891673 10.2353/ajpath.2007.060754
17. Song L.-B., Zeng M.-S., Liao W.-T., Zhang L., Mo H.-Y., Liu W.-L., Shao J.-Y., Wu Q.-L., Li M.-Z., Xia Y.-F., Fu L.-W., Huang W.-L., Dimri G. P., Band V., Zeng Y.-X., Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Research 2006 66 12 6225 6232 2-s2.0-33745685884 10.1158/0008-5472.CAN- 06-0094
18. Qin Z. K., Yang J. A., Ye Y. L., Zhang X., Xu L. H., Zhou F. J., Han H., Liu Z. W., Song L. B., Zeng M. S., Expression of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer 2009 9 61 10.1186/1471-2407-9-61
19. Liu J.-H., Song L.-B., Zhang X., Guo B.-H., Feng Y., Li X.-X., Liao W.-T., Zeng M.-S., Huang K.-H., Bmi-1 expression predicts prognosis for patients with gastric carcinoma. Journal of Surgical Oncology 2008 97 3 267 272 2-s2.0-39749120638 10.1002/jso.20934
20. Zhang F., Wang Z.-M., Liu H.-Y., Bai Y., Wei S., Li Y., Wang M., Chen J., Zhou Q.-H., Application of RT-PCR in formalin-fixed and paraffin-embedded lung cancer tissues. Acta Pharmacologica Sinica 2010 31 1 111 117 2-s2.0-74549120215 10.1038/aps.2009.178
21. Miltenburg D., Louw D. F., Sutherland G. R., Epidemiology of childhood brain tumors. Canadian Journal of Neurological Sciences 1996 23 2 118 122 2-s2.0-0030004388
22. Pollack I. F., Brain tumors in children. The New England Journal of Medicine 1994 331 22 1500 1507 2-s2.0-0027944927 10.1056/NEJM199412013312207
23. Sala F., Colarusso E., Mazza C., Talacchi A., Bricolo A., Brain tumors in children under 3 years of age: recent experience (1987-1997) in 39 patients. Pediatric Neurosurgery 1999 31 1 16 26 2-s2.0-0032719368 10.1159/000028826
24. Al-Hajj M., Clarke M. F., Self-renewal and solid tumor stem cells. Oncogene 2004 23 43 7274 7282 2-s2.0-5444256238 10.1038/sj.onc.1207947
25. Singh S. K., Clarke I. D., Hide T., Dirks P. B., Cancer stem cells in nervous system tumors. Oncogene 2004 23 43 7267 7273 2-s2.0-6044221204 10.1038/sj.onc.1207946
26. Sawa M., Yamamoto K., Yokozawa T., Kiyoi H., Hishida A., Kajiguchi T., Seto M., Kohno A., Kitamura K., Itoh Y., Asou N., Hamajima N., Emi N., Naoe T., BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. International Journal of Hematology 2005 82 1 42 47 2-s2.0-27244450787 10.1532/IJH97.05013
27. Leung C., Lingbeek M., Shakhova O., Liu J., Tanger E., Saremaslani P., Van Lohuizen M., Marino S., Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004 428 6980 337 341 2-s2.0-1642633053 10.1038/nature02385
28. -/- mice. Cancer Cell 2004 6 3 229 240 2-s2.0-4544285754 10.1016/j.ccr.2004.08.019